The induction of a TH1-type immune response is critical for resistance to many intracellular pathogens, including Toxoplasma gondii (10) . The events that lead to protective immunity are dependent on the production of interleukin 12 (IL-12), which drives the development of a TH1-type response dominated by the production of gamma interferon (IFN-␥). IFN-␥ is the major mediator of resistance to T. gondii (41) and is required for the activation of effector mechanisms that are essential for control of T. gondii (10) . The importance of T cells in resistance to T. gondii is best illustrated by the patients with acquired immune deficiencies who develop toxoplasmic encephalitis (TE). For example, patients with certain cancers, or who are being actively immunosuppressed to allow successful transplantation, are susceptible to reactivation of toxoplasmosis (21, 36) . Moreover, patients with AIDS become susceptible to TE as their T-cell counts fall (20) , which correlates with a reduction in the levels of IFN-␥ that they can produce (11) . The common characteristic of these patients is that they have an acquired defect in their T-cell functions that cripples the ability of the immune system to control T. gondii.
Interestingly, a role for the CD40/CD40 ligand (CD40L) interaction in resistance to T. gondii is indicated by the development of TE in pediatric patients with a primary defect in this receptor-ligand interaction (24, 42) . However, although the CD40/CD40L interaction is important for a number of immunological processes, it is unclear how this defect leads to susceptibility to TE. For example, the interaction of CD40L on T cells with CD40 on B cells is a critical signal required for isotype switching, and in the absence of this signal patients develop a hyper-immunoglobulin M (IgM) syndrome (26) . Moreover, the CD40/CD40L interaction is important in providing costimulation for T cells, has an important role in the maturation and activation of accessory cells to produce IL-12 and upregulate costimulatory molecules, and can directly activate macrophage effector functions (7, 15, 16, 23, 27, 30, 35, 38, 39, 43, 45) . Studies which have directly addressed the role of the CD40/CD40L interaction in immunity to T. gondii have shown that human macrophages infected with T. gondii upregulate their expression of CD40 and that the ability of live parasites to stimulate maximal production of IL-12 and IFN-␥ by human peripheral blood mononuclear cells (PBMCs) in vitro is dependent on the CD40/CD40L interaction (40) . However, studies in a murine system have demonstrated that intravenous treatment of mice with soluble toxoplasma antigens results in production of IL-12 by dendritic cells that is independent of the CD40/CD40L interaction (29) . Nevertheless, it is clear that patients deficient in CD40L signaling are highly susceptible to toxoplasmosis, but the mechanism whereby this interaction mediates resistance to T. gondii is uncertain.
In order to understand the role of the CD40/CD40L interaction in immunity to T. gondii the expression of CD40 was assessed following infection of C57BL/6 mice, and the effect of anti-CD40L antibodies on production of IL-12 and IFN-␥ during recall responses was measured. To address the role of this interaction in vivo, CD40L
Ϫ/Ϫ mice were infected with T. gondii, and the course of the infection was followed and immune responses of these mice were analyzed. Lastly, the ability of soluble CD40L (sCD40L) to activate macrophages in vitro to control parasite replication was assessed. Together, the results obtained suggest that the CD40/CD40L interaction has a limited role in the regulation of T-cell responses associated with resistance to T. gondii. Rather, this interaction may have a isothiocyanate-or phycoerythrin-conjugated streptavidin (PharMingen) for 20 min on ice. Cells were then washed with FACS buffer and analyzed. Antibodies and streptavidin reagents were used at dilutions empirically determined to give optimal staining for flow cytometric analyses. Results were analyzed by using CELL Quest software (Becton Dickinson).
Analysis of macrophage functions. Bone marrow macrophages (BMM) from C57BL/6 or B6/129 mice were derived from bone marrow cells grown on petri dishes (150 by 15 mm; Falcon; Becton Dickinson Labware, Paramus, New Jersey) in Dulbecco modified Eagle medium containing 20% (vol/vol) heat-inactivated fetal calf serum, 20% L-cell-conditioned medium, 100 U of penicillin/ml, and 100 g of streptomycin per ml. After at least 6 days of incubation at 37°C and 5% CO 2 in a humidified incubator, adherent cells were harvested by using ice-cold buffered saline without calcium or magnesium and washed three times in complete RPMI medium. For antitoxoplasma activity, 4 ϫ 10 5 BMM in complete RPMI medium were incubated at 37°C and 5% CO 2 in Falcon polypropylene tubes (Becton Dickinson) with medium alone or with 100 U of IFN-␥/ml, 20 g of sCD40L/ml, or the combination of IFN-␥ plus sCD40L. After 4 h, cultures were infected with RH tachyzoites at a ratio of one parasite to one macrophage for 2 h. Cells were then washed to remove free parasites, and cultures were replenished with IFN-␥, sCD40L, or the combination of these reagents. At 2 and 20 h postinfection 5 ϫ 10 4 cells were removed, cytospins were prepared, and cells were stained with DiffQuik (Dade Diagnostics, Aguada, P.R.). Baseline infections and the numbers of parasites per 100 infected cells were determined microscopically.
Statistics. INSTAT software (GraphPad, San Diego, Calif.) was used for the unpaired two-tailed Student t test, paired t test evaluations, or the Mann-Whitney nonparametric test. A P value of Ͻ0.05 was considered significant.
RESULTS

Expression of CD40 following infection with T. gondii.
C57BL/6 mice were inoculated i.p. with 20 cysts of T. gondii, and the expression of CD40 was assessed during the early phase of infection by using FACS. By day 5 postinfection, there were increased numbers of macrophages that expressed CD40 in the peritoneum (Fig. 1A and B) or spleens (data not shown) of infected mice. In addition, since C57BL/6 mice develop TE during the chronic phase of the infection, we used immunohistochemistry to assess expression of CD40 in the brains of mice with TE. Staining for CD40 revealed that brains from uninfected mice were negative for CD40 expression, but by 4 weeks postinfection there was intense staining for CD40 associated with areas of inflammation and parasite replication (data not shown). To further characterize the cell populations that expressed CD40 during TE, mononuclear cell populations were isolated from the brains of infected mice and analyzed by using FACS. These studies revealed that F4/80-positive cells, likely macrophages/microglia, expressed elevated levels of CD40 ( Fig. 1C and D ). These data demonstrate that following infection with T. gondii, the expression of CD40 is upregulated during the acute and chronic phases of disease. Effect of CD40L blockade on production of IL-12 and IFN-␥ during toxoplasmosis. Since the CD40/CD40L interaction has been shown to regulate IL-12 production and T-cell activation, it is possible that the increased expression of CD40 observed following infection is involved in the T. gondii-induced production of IL-12 and IFN-␥. To test this hypothesis, the CD40/ CD40L interaction was blocked with anti-CD40L MAb and the production of IL-12 and IFN-␥ by splenocytes from C57BL/6 mice infected with T. gondii for 5 days was measured (Fig. 2) . Stimulation of splenocytes from these mice with TLA resulted in the production of high levels of IFN-␥ and IL-12 ( Fig. 2) . The addition of anti-CD40L MAb to these cultures did not result in a statistically significant reduction (based on paired t test analysis of the data from five experiments) in the levels of these cytokines, although there was a trend towards decreased production of IL-12. Splenocytes from uninfected mice stimulated with TLA did not produce appreciable levels of IFN-␥; only low levels of IL-12 were detected, and these were not affected by addition of anti-CD40L MAb to these cultures (data not shown).
The increased expression of CD40 in the brain during TE suggested that this interaction may be important in the regulation of the immune response in the brain. Therefore, the role of CD40L in the production of IL-12 and IFN-␥ by splenocytes and BMNC from chronically infected C57BL/6 mice (10 weeks) was tested. Similar to the effects observed with splenocytes during acute infection, the inclusion of anti-CD40L MAb in these cultures did not result in a statistically significant reduction in the production of IFN-␥ or IL-12 ( Fig. 2) . However, we did observe that, similar to the results observed with splenocytes, blockade of CD40L resulted in a trend towards lower levels of IL-12. Together, these results suggest that the CD40L interaction has a limited role in the regulation of ex vivo production of IL-12 or IFN-␥ during toxoplasmosis.
CD40L is required for resistance to toxoplasmosis. Although the studies described above show that CD40L is not required for the in vitro production of IL-12 or IFN-␥, they do not address whether CD40L is involved in the initiation of these responses in vivo. To functionally test the significance of the CD40/CD40L interaction in resistance to T. gondii in an experimental system, wild-type (WT) and CD40L Ϫ/Ϫ mice were inoculated with the ME49 strain of T. gondii and the course of infection was assessed. WT mice with a B6/129 genetic background are relatively resistant to development of TE, and when these mice were infected with T. gondii they survived for the course of these studies (3 months postinfection). Comparison of the parasite burden in WT and CD40L Ϫ/Ϫ mice at day 7 postinfection revealed no significant differences in the percentage of PECs infected following i.p. challenge with T. gondii. In a typical experiment (of four performed) the mean percentage of cells infected in WT mice was 0.6% Ϯ 0.14% (mean Ϯ standard error [SE] ; n ϭ 6) whereas CD40L Ϫ/Ϫ mice had 0.39% Ϯ 0.07% of peritoneal cells infected. Statistical analysis revealed no significant difference between these experimental groups (P ϭ 0.2). However, although the CD40L Ϫ/Ϫ mice survived the acute phase of the infection, they were susceptible to the chronic phase of infection and died within 4 to 6 weeks (Fig. 3) . Analysis of the brains of mice infected for 4 weeks revealed that WT and CD40L Ϫ/Ϫ mice had a similar meningitis but the CD40L Ϫ/Ϫ mice had a more severe encephalitis associated with the presence of large numbers of cysts and areas of parasite replication (Fig. 4) . In several experiments CD40L Ϫ/Ϫ mice exhibited lung pathology that was more severe than that observed in WT mice. However, this was an inconsistent observation since lung pathologies in WT and CD40L Ϫ/Ϫ mice at 4 weeks postinfection were not different in other experiments (data not shown). Thus, similar to patients with defects in CD40L signaling, CD40L
Ϫ/Ϫ mice are susceptible to TE.
CD40L is not required for the generation or maintenance of TH1-type responses during toxoplasmosis. While initial studies indicated that the CD40/CD40L interaction was not required for the ex vivo production of IFN-␥ or IL-12 by cells from infected WT mice, it was still possible that the susceptibility of CD40L Ϫ/Ϫ mice to TE could be a consequence of an intrinsic defect in the production of these cytokines. Indeed, although infected CD40L Ϫ/Ϫ mice produced increased levels of IL-12 in serum and during recall responses, these levels were reduced compared with those in WT mice (Fig. 5A) . However, CD40L
Ϫ/Ϫ mice produced levels of IFN-␥ in serum and recall responses that were comparable to those in WT mice (Fig. 5B) . Thus, the defect in IL-12 production observed in the
CD40L
Ϫ/Ϫ mice did not have a significant effect on the infection-induced production of IFN-␥.
Although production of IFN-␥ in the periphery of infected WT and CD40L Ϫ/Ϫ mice was similar, the increased levels of inflammation present in the brains of infected CD40L Ϫ/Ϫ mice suggested that there may be differences in the intracerebral immune response between WT and CD40L Ϫ/Ϫ mice. Characterization of the inflammatory responses in the brains of these animals revealed that similar numbers of mononuclear cells were isolated from WT and CD40L Ϫ/Ϫ mice at 4 weeks postinfection (WT, 4.5 ϫ 10 6 Ϯ 1.2 ϫ 10 6 /brain; CD40L Ϫ/Ϫ , 3.9 ϫ 10 6 Ϯ 1.6 ϫ 10 6 /brain; P ϭ 0.32). While the relative percentages of CD8 ϩ T cells were similar (WT, 33.5% Ϯ 7.75% [mean Ϯ standard deviation]; CD40L Ϫ/Ϫ , 36.7% Ϯ 6%), there was a significant increase in the percentage (mean Ϯ standard deviation) of CD4 ϩ T cells in the CD40L Ϫ/Ϫ mice compared with WT (WT, 27.2% Ϯ 3.7%; CD40L Ϫ/Ϫ , 38.4% Ϯ 7.75; P ϭ 0.0173). These data indicate that CD40L is not required for the ability of T cells to traffic to the brain during TE. Cultured BMNC from WT and CD40L Ϫ/Ϫ mice produced high basal levels of IL-12 ( Fig. 6A ) that were not altered after stimulation with TLA (data not shown). However, BMNC from CD40L Ϫ/Ϫ mice produced significantly less IL-12 than BMNC from WT mice. Interestingly, BMNC from CD40L Ϫ/Ϫ mice produced levels of IFN-␥ that were comparable to levels of BMNC from WT mice (Fig. 6B ). These findings were further supported by RPA analysis of brain tissue from WT and CD40L Ϫ/Ϫ mice, 
FIG. 5. Analysis of IL-12 and IFN-␥ production during acute and chronic phases of toxoplasmosis in WT and CD40L
Ϫ/Ϫ mice. WT and CD40L Ϫ/Ϫ mice were infected with T. gondii, and groups of mice were sacrificed at 5 days or 4 weeks after infection. Serum was collected from mice infected for 5 days and assayed for levels of IL-12 (A) and IFN-␥ (B). Splenocytes from infected mice were stimulated in vitro with TLA, and the levels of IL-12 or IFN-␥ were measured by ELISA. Results presented are means plus SEs of the pooled data from three experiments. which demonstrated that there were similar levels of IFN-␥ mRNA in the brains of these mice (Fig. 6C) . These data suggest that the increased susceptibility of CD40L Ϫ/Ϫ mice to TE is not a consequence of a defect in the production of IFN-␥, either in the periphery or within the brain.
Stimulation through CD40 enhances the ability of macrophages to control replication of T. gondii. Although the production of IFN-␥ during toxoplasmosis was independent of the CD40/CD40L interaction, CD40L Ϫ/Ϫ mice were still highly susceptible to TE. These results suggested that the absence of CD40L may lead to a defect in effector cell function. Since the CD40/CD40L interaction can directly activate macrophages to produce antimicrobial effector molecules (38), we assessed whether stimulation through CD40 would affect the ability of macrophages to control replication of T. gondii. BMM from C57BL/6 mice were used to test this hypothesis. Macrophages infected with tachyzoites of T. gondii were unable to control parasite replication, and the addition of IFN-␥ (100 U/ml) or sCD40L alone did not affect the percentage of cells infected (Fig. 7A) . However, when IFN-␥ and sCD40L were used in combination, they significantly reduced the percentage of cells infected (n ϭ 6; P Ͻ 0.0001) (Fig. 7A) . In addition, the combination of sCD40L also resulted in a decrease in the number of parasites per 100 infected cells (Fig. 7B) . A similar reduction in the percentage of cells infected and numbers of parasites per 100 infected cells was observed when we used the stimulatory anti-CD40 MAb 4C11 instead of sCD40L (data not shown). Thus, stimulation through CD40 (when used in combination with IFN-␥) is able to activate macrophages to inhibit replication of T. gondii.
DISCUSSION
The CD40/CD40L interaction has been shown to be important in resistance to several intracellular parasites, including Leishmania species (4, 22, 37) , Cryptosporidium parvum (8) , and Pneumocystis carinii (44) . In those studies, the protective effect of CD40L was attributed primarily to its immunoregulatory properties, through either regulation of IL-12 production or, alternatively, production of antibody. It is well appreciated that stimulation of macrophages or dendritic cells through CD40 will lead to the production of IL-12, which is important for resistance to many intracellular pathogens. However, stimulation through CD40 will also affect maturation of dendritic cells and upregulate the expression of B7 on accessory cells and so enhance T-cell responses (16, 45) . In addition, the CD40/CD40L pathway can lead to direct stimulation of T cells (43) and has an important role in the initiation of T-cell responses and generation of effector cells (17, 39) . The studies presented here identify a critical role for the CD40/CD40L interaction in immunity to the important opportunistic pathogen T. gondii. However, our studies suggest that rather than being required for the development of a cell-mediated response that leads to the production of IFN-␥, CD40L may function in resistance to T. gondii by acting in concert with IFN-␥ to control parasite replication in the brain.
Recent studies have examined the role of the CD40/CD40L interaction in the generation of IL-12 and IFN-␥ by PBMCs from humans seronegative for T. gondii (40) . In those experiments, the production of IL-12 and IFN-␥ by PBMCs from healthy control patients stimulated with suboptimal numbers of tachyzoites was almost completely blocked by the addition of anti-CD40L. Moreover, PBMCs from patients with hyperIgM syndrome (who lack functional CD40L) were defective in their ability to produce IL-12 and IFN-␥ in response to T. gondii. These results suggest that the CD40/CD40L interaction has an important regulatory role in the initiation of resistance to T. gondii. In agreement with those findings, CD40L
Ϫ/Ϫ mice have a reduced ability to produce IL-12 during infection, and blockade of the CD40/CD40L interaction in recall responses from infected WT mice resulted in a trend towards decreased IL-12 production. Interestingly, the reduction in the levels of IL-12 produced by splenocytes and BMNC from CD40L Ϫ/Ϫ mice was more noteworthy than the effects of anti-CD40L on these populations from WT mice. These results suggest that the CD40/ CD40L interaction has an important role in priming accessory cells to produce IL-12 rather than being directly required for ex vivo production of IL-12.
In contrast to studies with human PBMCs, the IFN-␥ responses in both of these murine systems were unaffected by anti-CD40L or a complete absence of CD40L. Whether the differences in IFN-␥ production observed between CD40L Ϫ/Ϫ mice and human PBMCs indicate real differences between the role of CD40L in the regulation of human and murine immune responses to T. gondii or are simply a function of different experimental approaches is not clear. Nevertheless, like the hyper-IgM patients, mice deficient in the CD40/CD40L pathway are susceptible to T. gondii as well as the opportunistic parasites P. carinii and C. parvum. Interestingly, although there are reports of disseminated tuberculosis and histoplasmosis in patients that lack CD40L (25) , studies with mice infected with Mycobacterium tuberculosis (5) or Histoplasma capsulatum (48) demonstrated that the CD40/ CD40L interaction is not required for resistance to these pathogens. Thus, murine models of CD40L deficiency do not always correlate with human disease.
It has long been established that IFN-␥ is the major mediator of resistance to T. gondii in the periphery as well as in the brain (10) . In contrast, IL-12 is required for the initiation of the protective TH1-type response but is not required for the control of TE (13) . In support of those studies, the defective production of IL-12 in the brains of CD40L Ϫ/Ϫ mice did not appear to affect the production of IFN-␥ at this site. However, it should be noted that although CD8 ϩ T cells are regarded as the major source of IFN-␥ during TE there was an increase in the percentage of CD4
ϩ T cells present in the BMNC derived from the CD40L Ϫ/Ϫ mice with TE. Nevertheless, it is unlikely that the reduced levels of IL-12 produced by BMNC from CD40L Ϫ/Ϫ mice are the cause of the enhanced parasite replication and severe TE observed in the CD40L Ϫ/Ϫ mice. Therefore, if CD40L is not required for regulation of protective T-cell responses (as measured by production of IFN-␥) in the brain, what is its role in controlling T. gondii at this site? The finding that sCD40L stimulation can enhance the ability of macrophages to control parasite replication offers a possible explanation. The presence of activated T cells in the brain during TE (28) and the immunohistochemical detection of CD40L at this site (C. A. Hunter, unpublished observations) suggest that T cells could be directly involved in the local activation of antiparasite effector mechanisms. Experiments are currently ongoing to address this issue. However, these findings raise several questions about the role of CD40L and tumor necrosis factor alpha (TNF-␣) in the activation of effector functions required for resistance to T. gondii. Several studies have identified TNF-␣ (9, 46) and inducible nitric oxide synthase (iNOS) (32) as being critical for resistance to T. gondii in the brain. The protective effect of TNF-␣ in the brain was attributed to the ability of TNF-␣ to act as a second signal for IFN-␥-activated macrophages to produce NO. Whether there are reduced levels of iNOS in the brains of mice that lack TNF or TNF signaling is controversial. Original studies in which mice were treated with anti-TNF-␣ MAb reported that the enhanced susceptibility to TE correlated with reduced levels of iNOS mRNA (12) and similar results were reported with mice deficient in the p55 TNF-receptor (TNF-R) (9) . In contrast, studies with mice deficient in both the p55 and p75 TNF-R and infected with T. gondii reported that iNOS levels in the brains of these mice were normal (46) . We have also observed that there are elevated levels of iNOS protein in the brains of p55 TNF-R Ϫ/Ϫ mice during TE (W. Walker and C. A. Hunter, unpublished data) as well as in mice treated with anti-TNF-␣ MAb (G. Reichmann and C. A. Hunter, unpublished data), suggesting that there is a TNF-␣-independent mechanism that is operative in the central nervous system that leads to activation of iNOS. Given the similar phenotypes of the TNF-R Ϫ/Ϫ and CD40L Ϫ/Ϫ mice (both die of TE) and that CD40L and TNF-␣ are members of the same cytokine superfamily, use similar signaling pathways, and can enhance macrophage production of NO, it is possible that TNF-␣ and CD40L are both required for maximal induction of NO production during TE. Interestingly, our initial studies have found that BMNC from chronically infected CD40L
Ϫ/Ϫ mice produce normal levels of NO, and immunohistochemistry has shown the presence of iNOS protein in the brains of these mice (unpublished observations). Together with the previous studies on TNF-R-deficient mice, these findings suggest the possibility that the ability of TNF-␣ and/or CD40L to mediate killing of T. gondii in the brain may involve NO-dependent as well as NO-independent pathways. Interestingly, Yap and Sher provided evidence for iNOS-dependent and -independent mechanisms of resistance to T. gondii in the brain (47) . Further studies are needed to directly determine the mechanism whereby different TNF family members mediate resistance to T. gondii in the brain.
The regulation of protective immunity to T. gondii in the brain is complex, and the studies presented here add to our knowledge of the molecules involved in this process. It is clear that CD40L is required to control parasite replication in the brain, and recent studies support a role for CD40L in the immunopathogenesis of other neuroimmune diseases. The CD40/CD40L interaction is required for activated TH1 cells to stimulate microglia to produce IL-12 (2) , and this interaction is thought to be involved in the pathogenesis of multiple sclerosis (3, 14) . Moreover, in support of the findings presented here, Howard and colleagues suggested that the ability of anti-CD40 MAb to inhibit adoptive experimental allergic encephalomyelitis supports a role for CD40L in the ability of T cells to activate macrophage/microglia effector functions in the brain (18) . Thus, the CD40/CD40L interaction is not restricted to the regulation of immune responses but appears to have an important role in effector functions at local sites of infection and inflammation.
